Evenamide
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Evenamide, covering 2021-05-20 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia [Phase 3]